Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04655599

Title field or adapter rule

{'original_value': 'Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:35.249034+00:00

Published At

2021-05-17T00:00:00+00:00

Record Updated At

2021-05-17

Source Retrieved At

2026-10-31T22:18:52.668840+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Irritable Bowel Syndrome"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2021-05-17", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT04655599"

protocolSection.identificationModule.officialTitle

"Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome"

protocolSection.statusModule.overallStatus

"TERMINATED"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Irritable Bowel Syndrome (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Olorinab, Then Placebo', 'Placebo, Then Olorinab'], 'description': 'Olorinab tablet by mouth, 3 times a day for 4 days with a final dose on Day 5.', 'name': 'Olorinab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Olorinab, Then Placebo', 'Placebo, Then Olorinab'], 'description': 'Olorinab matching placebo tablet by mouth, 3 times a day for 4 days with a final dose on Day 5.', 'name': 'Placebo', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Olorinab (protocolSection.armsInterventionsModule.interventions[].name)
• Placebo (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.